Sex hormones promote immunoregulatory effects on multiple sclerosis. The current study evaluated estrogen effects on regulatory B cells and resident CNS microglia during experimental autoimmune encephalomyelitis (EAE). Herein, we demonstrate an estrogen-dependent induction of multiple regulatory B cell markers indicative of IL-10 dependent as well as IFN-γ dependent pathways. Moreover, although estrogen pretreatment of EAE mice inhibited the infiltration of pro-inflammatory cells into the CNS, it enhanced the frequency of regulatory B cells and M2 microglia. Our study suggests that estrogen has a broad effect on the development of regulatory B cells during EAE, which in turn could promote neuroprotection.
Introduction
Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system (CNS) (Frohman et al., 2006; Sospedra and Martin, 2005; Steinman, 2001) . Although the incidence of relapsing-remitting MS is higher in women, with a female/male sex ratio of~3:1, the relapse rates decrease during late pregnancy (Confavreux et al., 1998; Vukusic et al., 2004; Whitacre, 2001) . Moreover, sex hormones may have immunoregulatory activity and may prevent MS exacerbations during pregnancy. We and others demonstrated that treatment of experimental autoimmune encephalomyelitis (EAE) -the murine MS model -with pregnancy levels of estriol reduces CNS inflammation through induction of regulatory T and B cells (Garidou et al., 2004; Offner and Polanczyk, 2006; Polanczyk et al., 2003) . Moreover, it was shown that the frequency of IL-10 producing B cells (B10) increases during normal pregnancy (Fettke et al., 2014; Jensen et al., 2013) . In agreement with these studies, we previously reported that estrogen-induced protection against EAE is B cell dependent and that this protection also depends on the expression of programmed death-ligand 1 (PD-L1) on B10 cells (Bodhankar et al., 2013a; Zhang et al., 2015a) .
While B cells contribute to the pathogenesis of EAE through the production of anti-myelin antibodies and as antigen presenting cells (Molnarfi et al., 2013; Owens et al., 2009 ), accumulated evidence suggests that regulatory B cells (Bregs) have a critical role in suppressing neuro-inflammation during EAE and reducing the number of infiltrating pro-inflammatory cells into the CNS (Bodhankar et al., 2011; Matsushita et al., 2008; Ray et al., 2011; Wolf et al., 1996) et al., 2007; Matsumoto et al., 2014; Matsushita et al., 2008; Mauri and Bosma, 2012; Xiao et al., 2015; Yeung et al., 2015) . In addition, Bregs were shown to have an IL-10 independent mechanism of action. Recently, it was reported that PD-L1 hi B cells could mediate immunesuppression independent of IL-10 (Khan et al., 2015) . However, the mechanisms by which estrogen induces Breg protection during the course of MS and EAE have not yet been fully characterized. Another aspect of the estrogen's neuro-protective role is its effect on microglia activation. Classically activated macrophages (M1) govern the CNS during the early stages of the disease, secreting pro-inflammatory cytokines and activating effector T cells. During the later phase of Journal of Neuroimmunology 293 (2016) [45] [46] [47] [48] [49] [50] [51] [52] [53] 
